Impact of IL28B and OAS gene family polymorphisms on interferon treatment response in Caucasian children chronically infected with hepatitis B virus

被引:0
|
作者
Krzysztof Domagalski [1 ]
Ma?gorzata Paw?owska
Agnieszka Zale?na
Ma?gorzata Pilarczyk
Pawe? Rajewski
Waldemar Halota [2 ]
Andrzej Tretyn [4 ]
机构
[1] Centre for Modern Interdisciplinary Technologies, Nicolaus Copernicus University
[2] Provincial Infectious Diseases Hospital in Bydgoszcz  4. Department of Plant Physiology and Biotechnology, Nicolaus Copernicus University
[3] Department of Paediatric Infectious Diseases and Hepatology, Faculty of Medicine, Collegium Medicum Bydgoszcz, Nicolaus Copernicus University Torun
关键词
Chronic hepatitis B; IL28B; OAS; Singlenucleotide polymorphisms; IFN therapy; Children;
D O I
暂无
中图分类号
R725.1 [小儿传染病];
学科分类号
100202 ;
摘要
AIM To investigate the impact of IL28 B and OAS gene polymorphisms on interferon treatment responses in children with chronic hepatitis B.METHODS We enrolled 52 children(between the ages of 4 and 18) with hepatitis B e antigen-negative chronic hepatitis B(CHB), who were treated with pegylated interferon alfa for 48 wk. Single nucleotide polymorphisms in the OAS1(rs1131476), OAS2(rs1293747),OAS3(rs2072136), OASL(rs10849829) and IL28B(rs12979860, rs12980275 and rs8099917) genes were studied to examine their associations with responses to IFN treatment in paediatric patients. We adopted two criteria for the therapeutic response, achieving an hepatitis B virus(HBV) DNA level < 2000 IU/m L and normalization of ALT activity(< 40 IU/L). To perform the analyses, we compared the patients in terms of achieving a partial response(PR) and a complete response(CR) upon measurement at the 24-wk posttreatment follow-up. RESULTS The PR and CR rates were 80.8% and 42.3%, respectively. Factors such as age, gender and liver histology had no impact on the type of response(partial or complete). A statistically significant relationship between higher baseline HBV DNA and ALT activity levels and lower rates of PR and CR was shown(P < 0.05). The allele association analysis revealed that only the IL-28 B rs12979860(C vs T) and IL28 B rs12980275(A vs G) markers significantly affected the achievement of PR(P = 0.021, OR = 3.3, 95%CI: 1.2-9.2 and P = 0.014, OR = 3.7, 95%CI: 1.3-10.1, respectively). However, in the genotype analysis, only IL-28 B rs12980275 was significantly associated with PR(AA vs AG-GG, P = 0.014, OR = 10.9, 95%CI: 1.3-93.9). The association analysis for CR showed that the TT genotype of IL28 B rs12979860 was present only in the no-CR group(P = 0.033) and the AA genotype of OASL rs10849829 was significantly more frequent in the noCR group(P = 0.044, OR = 0.26, 95%CI: 0.07-0.88). The haplotype analysis revealed significant associations between PR and CR and OAS haplotype(P = 0.0002 and P = 0.001, respectively), but no association with IL28 B haplotype was observed.CONCLUSION IL28 B and OAS polymorphisms are associated with different clinical outcomes in CHB children treated with interferon.
引用
收藏
页码:9186 / 9195
页数:10
相关论文
共 50 条
  • [21] Closed tube method for rapid screening of IL28B polymorphisms involved in response to hepatitis C treatment
    Habalova, Viera
    Klimcakova, Lucia
    Zidzik, Jozef
    Vasovcak, Peter
    Kristian, Pavol
    Valkova, Ivana
    Schreter, Ivan
    Salagovic, Jan
    MOLECULAR AND CELLULAR PROBES, 2012, 26 (04) : 159 - 163
  • [22] IL28B polymorphisms associated with therapy response in Chilean chronic hepatitis C patients
    Venegas, Mauricio
    Villanueva, Rodrigo A.
    Gonzalez, Katherine
    Brahm, Javier
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (31) : 3636 - 3639
  • [23] IL28B polymorphisms associated with therapy response in Chilean chronic hepatitis C patients
    Mauricio Venegas
    Rodrigo A Villanueva
    Katherine González
    Javier Brahm
    World Journal of Gastroenterology, 2011, 17 (31) : 3636 - 3639
  • [24] Impact of IL-28B polymorphisms on pegylated interferon plus ribavirin treatment response in children and adolescents infected with HCV genotypes 1 and 4
    Domagalski, K.
    Pawlowska, M.
    Tretyn, A.
    Halota, W.
    Pilarczyk, M.
    Smukalska, E.
    Linkowska, K.
    Grzybowski, T.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2013, 32 (06) : 745 - 754
  • [25] Impact of IL28B genetic variant's and viral genotype on treatment outcome of hepatitis C infected patients
    Khan, Mosin S.
    Shoukat, Abid
    Mudassar, Syed
    Kawoosa, Zaffar
    Shah, Altaf H.
    Zargar, Showkat A.
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2018, 12 (09): : 762 - 770
  • [26] A meta-analysis of the association between IL28B polymorphisms and infection susceptibility of hepatitis B virus in Asian population
    Chen, Jing
    Wang, Wei
    Li, Xiaoguang
    Xu, Jie
    BMC GASTROENTEROLOGY, 2015, 15
  • [27] A meta-analysis of the association between IL28B polymorphisms and infection susceptibility of hepatitis B virus in Asian population
    Jing Chen
    Wei Wang
    Xiaoguang Li
    Jie Xu
    BMC Gastroenterology, 15
  • [28] Gene polymorphisms of interleukin 28B and the risk to chronic hepatitis B virus infection in Thai
    Kimkong, I.
    Chankaew, J.
    Kunanopparat, A.
    Hirankarn, N.
    Tangkijvanich, P.
    TISSUE ANTIGENS, 2015, 85 (03): : 177 - 181
  • [29] Association of IL28B genotype and viral response of hepatitis C virus genotype 2 to interferon plus ribavirin combination therapy
    Akuta, Norio
    Suzuki, Fumitaka
    Seko, Yuya
    Kawamura, Yusuke
    Sezaki, Hitomi
    Suzuki, Yoshiyuki
    Hosaka, Tetsuya
    Kobayashi, Masahiro
    Kobayashi, Mariko
    Saitoh, Satoshi
    Arase, Yasuji
    Ikeda, Kenji
    Kumada, Hiromitsu
    JOURNAL OF MEDICAL VIROLOGY, 2012, 84 (10) : 1593 - 1599
  • [30] The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin
    Zobair M Younossi
    Aybike Birerdinc
    Mike Estep
    Maria Stepanova
    Arian Afendy
    Ancha Baranova
    Journal of Translational Medicine, 10